サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1507198

MCED（複数がん早期発見）市場、シェア、規模、動向、産業分析レポート、予測、2024年～2032年

Multi Cancer Early Detection Market Share, Size, Trends, Industry Analysis Report Forecast, 2024 - 2032

出版日
ページ情報
英文 116 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円
MCED（複数がん早期発見）市場、シェア、規模、動向、産業分析レポート、予測、2024年～2032年
出版日: 2024年06月01日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のMCED（複数がん早期発見）市場規模は2032年までに39億3,479万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

MCED（複数がん早期発見）市場は、ゲノミクス、バイオテクノロジー、人工知能の進歩によって急速に進化しています。この市場は、多くの場合血液検査などの非侵襲的な方法を用いて、1つのサンプルから複数のがん種を検出できる診断検査の開発と商品化に焦点を当てています。その目的は、がんを治療可能な早期段階で特定し、患者の転帰を改善し、ヘルスケアコストを削減することです。

複数のがん早期発見市場が成長する要因はいくつかあります。第一に、世界のがん罹患率の増加と早期発見の利点に対する意識の高まりが、革新的な診断ソリューションに対する需要を煽っています。世界保健機関（WHO）によると、がんは世界の主要な死因であり、今後20年間で新規症例は約60％増加すると予想されています。第二に、ゲノミクスと分子生物学の技術的進歩により、がんを極めて早期に発見できる高感度で特異的なバイオマーカーが開発されています。各社はこうした進歩を活用し、日常臨床に組み込むことのできる複数のがんスクリーニング検査を開発しています。

さらに、官民双方による研究開発への多額の投資が、この分野における技術革新のペースを加速させています。政府や保健機関も、早期発見イニシアチブを支援する動きを強めており、命を救い、長期的なヘルスケア支出を削減する可能性を認識しています。さらに、個別化医療の普及と予防医療へのシフトは、より広範な検診プログラムへのMCED（複数がん早期発見）検査の統合を促しています。これらの促進要因を総合すると、MCED（複数がん早期発見）市場は今後数年間で大きく成長し、がん診断と患者ケアを変革することが期待されます。

MCED（複数がん早期発見）市場レポートハイライト

リキッドバイオプシーに向けた調査の増加により、リキッドバイオプシー分野は最も速いCAGRで成長すると予測されます。

診断ラボ部門は、個別化医療に対する意識の高まり、手頃な価格のサービスに対する需要の高まりにより急成長が見込まれる

APACは、がん患者数の増加と生存率を高める必要性の高まりにより、大幅な成長率が見込まれる

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のMCED（複数がん早期発見）市場の洞察

  • 業界スナップショット
  • MCED（複数がん早期発見）市場力学
    • 促進要因と機会
      • AI統合によるがんスクリーニングの変革をもたらすマルチがん早期検出（MCED）テスト
      • がん検出率の向上
    • 抑制要因と課題
      • MCED（複数がん早期発見）検査を取り巻く潜在的なリスクと不確実性
  • ポーターのファイブフォース分析
  • PESTLE分析
  • MCED（複数がん早期発見）業界の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のMCED（複数がん早期発見）市場：タイプ別

  • 主な調査結果
  • イントロダクション
  • 液体生検
  • 遺伝子パネル、LDT
  • その他

第6章 世界のMCED（複数がん早期発見）市場：エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 病院
  • 診断ラボ
  • その他

第7章 世界のMCED（複数がん早期発見）市場：地域

  • 主な調査結果
  • イントロダクション
    • MCED（複数がん早期発見）市場評価：地域、2019-2032年
  • 北米
    • 北米：エンドユーザー別、2019～2032年
    • 北米：タイプ別、2019-2032年
    • 米国
    • カナダ
  • 欧州
    • 欧州：エンドユーザー別、2019年～2032年
    • 欧州：タイプ別、2019-2032
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
  • アジア太平洋地域
    • アジア太平洋地域：エンドユーザー別、2019年～2032年
    • アジア太平洋：タイプ別、2019-2032
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
  • 中東・アフリカ
    • 中東およびアフリカ：エンドユーザー別、2019-2032年
    • 中東・アフリカ：タイプ別、2019年～2032年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：エンドユーザー別、2019年～2032年
    • ラテンアメリカ：タイプ別、2019-2032年
    • メキシコ
    • ブラジル
    • アルゼンチン

第8章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • Illumina, Inc.（GRAIL, LLC）
  • Exact Sciences Corp.
  • Foundation Medicine, Inc
  • AnchorDx
  • Guardant Health
  • Burning Rock Biotech Ltd
  • GENECAST
  • Beijing Lyman Juntai International Medical Technology Development Co
  • Freenome Holdings, Inc.
  • Elypta AB
図表

List of Tables

  • Table 1 Global Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 2 Global Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 3 Multi Cancer Early Detection Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 4 North America: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 5 North America: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 6 U.S.: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 7 U.S.: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 8 Canada: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 9 Canada: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 10 Europe: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 11 Europe: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 12 UK: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 13 UK: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 14 France: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 15 France: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 16 Germany: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 17 Germany: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 18 Italy: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 19 Italy: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 20 Spain: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 21 Spain: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 22 Netherlands: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 23 Netherlands: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 24 Russia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 25 Russia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 26 Asia Pacific: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 27 Asia Pacific: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 28 China: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 29 China: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 30 India: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 31 India: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 32 Malaysia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 33 Malaysia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 34 Japan: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 35 Japan: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 36 Indonesia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 37 Indonesia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 38 South Korea: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 39 South Korea: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 40 Middle East & Africa: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 41 Middle East & Africa: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 42 Saudi Arabia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 43 Saudi Arabia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 44 UAE: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 45 UAE: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 46 Israel: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 47 Israel: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 48 South Africa: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 49 South Africa: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 50 Latin America: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 51 Latin America: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 52 Mexico: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 53 Mexico: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 54 Brazil: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 55 Brazil: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • Table 56 Argentina: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • Table 57 Argentina: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)

List of Figures

  • Figure 1 Global Multi Cancer Early Detection Market, 2019-2032 (USD Million)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by End User
  • Figure 7 Global Multi Cancer Early Detection Market, by End User, 2022 & 2032 (USD Million)
  • Figure 8 Market by Type
  • Figure 9 Global Multi Cancer Early Detection Market, by Type, 2022 & 2032 (USD Million)
  • Figure 10 Multi Cancer Early Detection Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 11 Strategic Analysis - Multi Cancer Early Detection Market
目次
Product Code: PM4952

The global multi cancer early detection market size is expected to reach USD 3,934.79 million by 2032, according to a new study by Polaris Market Research. The report "Multi Cancer Early Detection Market Size, Share & Trends Analysis Report, By Type (Liquid Biopsy, Gene Panel, LDT & Others), By End-use (Hospitals, Diagnostic Laboratories), By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The multi-cancer early detection market is rapidly evolving, driven by advances in genomics, biotechnology, and artificial intelligence. This market focuses on the development and commercialization of diagnostic tests capable of detecting multiple cancer types from a single sample, often using non-invasive methods such as blood tests. The aim is to identify cancer at an early, more treatable stage, improving patient outcomes and reducing healthcare costs.

Several factors are driving the growth of the multi-cancer early detection market. Firstly, the increasing global incidence of cancer, coupled with the rising awareness of the benefits of early detection, fuels demand for innovative diagnostic solutions. According to the World Health Organization, cancer is a leading cause of death worldwide, with new cases expected to rise by approximately 60% over the next two decades. Secondly, technological advancements in genomics and molecular biology have led to the development of highly sensitive and specific biomarkers that can detect cancer at very early stages. Companies are leveraging these advancements to create multi-cancer screening tests that can be integrated into routine clinical practice.

Additionally, substantial investments in research and development by both private and public sectors are accelerating the pace of innovation in this field. Governments and health organizations are also increasingly supporting early detection initiatives, recognizing their potential to save lives and reduce long-term healthcare expenditures. Furthermore, the growing adoption of personalized medicine and the shift towards preventive healthcare are encouraging the integration of multi-cancer early detection tests into broader health screening programs. Collectively, these driving factors position the multi-cancer early detection market for significant growth in the coming years, promising to transform cancer diagnostics and patient care.

Multi Cancer Early Detection Market Report Highlights

The liquid biopsy segment is anticipated to grow at the fastest CAGR, owing rise in research towards liquid biopsies

The diagnostic laboratories segment will grow with rapid pace, due to the increased awareness of personalized medicine, rise in demand for affordable services

APAC expected to witness substantial growth rate, due to rising number of cancer cases and rising need to increase survival rate

The global players include Illumina, Sciences Corp., Foundation Medicine, AnchorDxFreewomen, and Elypta

Polaris Market Research has segmented the Multi Cancer Early Detection Market report based on type, end use, and region:

Multi Cancer Early Detection, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Liquid Biopsy
  • Gene Panel, LDT & Others

Multi Cancer Early Detection End-use Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Diagnostic Laboratories
  • Other

Multi Cancer Early Detection, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Multi Cancer Early Detection Market Insights

  • 4.1. Multi Cancer Early Detection Market - Industry Snapshot
  • 4.2. Multi Cancer Early Detection Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Multi-Cancer Early Detection (MCED) Tests Transforming Cancer Screening with AI Integration
      • 4.2.1.2. Enhancing Cancer Detection Rates
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Potential Risks and Uncertainties Surrounding Multi-Cancer Early Detection Tests
  • 4.3. Porter's Five Forces Analysis<
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Multi Cancer Early Detection Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Multi Cancer Early Detection Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Multi Cancer Early Detection, by Type, 2019-2032 (USD Million)
  • 5.3. Liquid Biopsy
    • 5.3.1. Global Multi Cancer Early Detection Market, by Liquid Biopsy, by Region, 2019-2032 (USD Million)
  • 5.4. Gene Panel, LDT
    • 5.4.1. Global Multi Cancer Early Detection Market, by Gene Panel, LDT, by Region, 2019-2032 (USD Million)
  • 5.5. Others
    • 5.5.1. Global Multi Cancer Early Detection Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Multi Cancer Early Detection Market, by End User

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Global Multi Cancer Early Detection Market, by Hospitals, by Region, 2019-2032 (USD Million)
  • 6.4. Diagnostic Laboratories
    • 6.4.1. Global Multi Cancer Early Detection Market, by Diagnostic Laboratories, by Region, 2019-2032 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Multi Cancer Early Detection Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Multi Cancer Early Detection Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Multi Cancer Early Detection Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Multi Cancer Early Detection Market - North America
    • 7.3.1. North America: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
    • 7.3.2. North America: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.3.3. Multi Cancer Early Detection Market - U.S.
      • 7.3.3.1. U.S.: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.3.4. Multi Cancer Early Detection Market - Canada
      • 7.3.4.1. Canada: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • 7.4. Multi Cancer Early Detection Market - Europe
    • 7.4.1. Europe: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
    • 7.4.2. Europe: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.3. Multi Cancer Early Detection Market - UK
      • 7.4.3.1. UK: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.4. Multi Cancer Early Detection Market - France
      • 7.4.4.1. France: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.4.2. France: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.5. Multi Cancer Early Detection Market - Germany
      • 7.4.5.1. Germany: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.6. Multi Cancer Early Detection Market - Italy
      • 7.4.6.1. Italy: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.7. Multi Cancer Early Detection Market - Spain
      • 7.4.7.1. Spain: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.8. Multi Cancer Early Detection Market - Netherlands
      • 7.4.8.1. Netherlands: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.4.9. Multi Cancer Early Detection Market - Russia
      • 7.4.9.1. Russia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • 7.5. Multi Cancer Early Detection Market - Asia Pacific
    • 7.5.1. Asia Pacific: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.5.3. Multi Cancer Early Detection Market - China
      • 7.5.3.1. China: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.5.3.2. China: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.5.4. Multi Cancer Early Detection Market - India
      • 7.5.4.1. India: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.5.4.2. India: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.5.5. Multi Cancer Early Detection Market - Malaysia
      • 7.5.5.1. Malaysia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.5.6. Multi Cancer Early Detection Market - Japan
      • 7.5.6.1. Japan: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.5.7. Multi Cancer Early Detection Market - Indonesia
      • 7.5.7.1. Indonesia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.5.8. Multi Cancer Early Detection Market - South Korea
      • 7.5.8.1. South Korea: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • 7.6. Multi Cancer Early Detection Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.6.3. Multi Cancer Early Detection Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.6.4. Multi Cancer Early Detection Market - UAE
      • 7.6.4.1. UAE: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.6.5. Multi Cancer Early Detection Market - Israel
      • 7.6.5.1. Israel: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.6.6. Multi Cancer Early Detection Market - South Africa
      • 7.6.6.1. South Africa: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
  • 7.7. Multi Cancer Early Detection Market - Latin America
    • 7.7.1. Latin America: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.7.3. Multi Cancer Early Detection Market - Mexico
      • 7.7.3.1. Mexico: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.7.4. Multi Cancer Early Detection Market - Brazil
      • 7.7.4.1. Brazil: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)
    • 7.7.5. Multi Cancer Early Detection Market - Argentina
      • 7.7.5.1. Argentina: Multi Cancer Early Detection Market, by End User, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Multi Cancer Early Detection Market, by Type, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Illumina, Inc. (GRAIL, LLC)
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Exact Sciences Corp.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Foundation Medicine, Inc
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. AnchorDx
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Guardant Health
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Burning Rock Biotech Ltd
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. GENECAST
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Beijing Lyman Juntai International Medical Technology Development Co
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Freenome Holdings, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Elypta AB
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development